These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1662116)

  • 21. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity.
    Yoshimura A; Longmore G; Lodish HF
    Nature; 1990 Dec; 348(6302):647-9. PubMed ID: 2174515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
    Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
    Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
    Yamashita T; Wakao H; Miyajima A; Asano S
    Cancer Res; 1998 Feb; 58(3):556-61. PubMed ID: 9458105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells.
    Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S
    Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene.
    Hoatlin ME; Kozak SL; Lilly F; Chakraborti A; Kozak CA; Kabat D
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9985-9. PubMed ID: 2175917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias.
    Moreau-Gachelin F; Ray D; Mattei MG; Tambourin P; Tavitian A
    Oncogene; 1989 Dec; 4(12):1449-56. PubMed ID: 2594367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin receptors induced by dimethyl sulfoxide exhibit positive cooperativity associated with an amplified biologic response.
    Yonekura S; Chern Y; Donahue KA; Feldman L; Vanasse GJ; Sytkowski AJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2535-9. PubMed ID: 1848708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the structure-function relationship of the leukemogenic membrane glycoprotein (GP55) of Friend spleen focus-forming virus (F-SFFV).
    Amanuma H; Yugawa T; Watanabe N; Ikawa Y
    Leukemia; 1997 Apr; 11 Suppl 3():160-1. PubMed ID: 9209329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells.
    Chretien S; Moreau-Gachelin F; Apiou F; Courtois G; Mayeux P; Dutrillaux B; Cartron JP; Gisselbrecht S; Lacombe C
    Blood; 1994 Apr; 83(7):1813-21. PubMed ID: 8142650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
    Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
    Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of alternative splicing of the rat erythropoietin receptor gene in normal and erythroleukemia cells.
    Fujita M; Takahashi R; Liang P; Saya H; Ashoori F; Tachi M; Kitazawa S; Maeda S
    Leukemia; 1997 Apr; 11 Suppl 3():444-5. PubMed ID: 9209419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncated erythropoietin receptor in a murine erythroleukemia cell line.
    Bittorf T; Busfield SJ; Klinken SP; Tilbrook PA
    Int J Biochem Cell Biol; 1996 Feb; 28(2):175-81. PubMed ID: 8729004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.
    Nishigaki K; Thompson D; Hanson C; Yugawa T; Ruscetti S
    J Virol; 2001 Sep; 75(17):7893-903. PubMed ID: 11483734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias.
    Moreau-Gachelin F; Tavitian A; Tambourin P
    Nature; 1988 Jan; 331(6153):277-80. PubMed ID: 2827041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SPI-1 transforming properties depend upon specifically activated forms of the EPOR.
    Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT
    Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
    Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
    Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of viral carcinogenesis by Phyllanthus amarus.
    Harikumar KB; Kuttan G; Kuttan R
    Integr Cancer Ther; 2009 Sep; 8(3):254-60. PubMed ID: 19815595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human erythropoietin receptor: cloning, expression, and biologic characterization.
    Jones SS; D'Andrea AD; Haines LL; Wong GG
    Blood; 1990 Jul; 76(1):31-5. PubMed ID: 2163696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.